The target of adalimumab is the protein tumor necrosis factor-alpha (TNFa). TNFa is involved in the body’s defense reactions. In the diseases mentioned above, the amount of TNFa is increased. This medicine attaches to TNFa and thereby reduces the inflammatory processes in these diseases.
Idacio 40 mg solution for injection in a pre-filled pen,2pcs
€1,442.00
This medicine contains the active ingredient adalimumab, a medicine that works on your body’s immune system (the body’s own defense system).
Description
Additional information
| Weight | 0.10 kg |
|---|---|
| Producing country | |
| Manufacturer |
Axicorp Pharma GmbH |
| Dosage form | |
| Usage | |
| EAN |
AP-16879715 |
Shipping & Delivery
